Z-0675-2019 Class II Terminated
FDA device recall Z-0675-2019 was initiated by Tosoh Bioscience Inc on Nov 30, 2018 and is designated Class II. The recall status is terminated (terminated Jan 14, 2021). Affected quantity: 992 units.
Recall details
- Product Type
- Devices
- Report Date
- Jan 2, 2019
- Initiation Date
- Nov 30, 2018
- Termination Date
- Jan 14, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 992 units
Product description
ST AIA-PACK Homocysteine (HCY) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of homocysteine in human serum, heparinized plasma or EDT A plasma on TOSOH AIA System Analyzers. Homocysteine measurements are used in the diagnosis and treatment of hyperhomocysteinemia or homocysteinuria.
Distribution pattern
US Nationwide
Code information
all lots
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0675-2019
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Tosoh Bioscience Inc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.